Axsome Therapeutics (AXSM) Intangibles (2022 - 2026)

Axsome Therapeutics' Intangibles history runs 5 years deep, the most recent figure standing at $38.9 million for Q1 2026.

• In Q1 2026, Intangibles fell 38.95% year-over-year to $38.9 million; the TTM figure through Mar 2026 stood at $38.9 million (down 38.95% YoY), while the FY2025 annual figure was $63.8 million, up 36.05% from the prior year.
• Intangibles came in at $38.9 million for Q1 2026 at Axsome Therapeutics, down from $63.8 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $63.8 million in Q2 2022 to a low of $38.9 million in Q1 2026.
• A 5-year average of $57.9 million and a median of $61.7 million in 2022 frame the typical range for Intangibles.
• Across the five-year window, Intangibles surged 36.05% in 2025 and plunged 38.95% in 2026, its largest moves.
• Axsome Therapeutics' Intangibles stood at $59.7 million in 2022, then slipped by 10.69% to $53.3 million in 2023, then fell by 12.0% to $46.9 million in 2024, then jumped by 36.05% to $63.8 million in 2025, then slumped by 38.95% to $38.9 million in 2026.
• According to Business Quant data, Intangibles over the past three periods registered $38.9 million, $63.8 million, and $63.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison